| Tretinoin | Approved Investigational Nutraceutical | ARHGEF28 | 64283 |
downregulated | Tretinoin results in decreased expression of ARHGEF28 mRNA | 5q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF3 | 50650 |
upregulated | Tretinoin results in increased expression of ARHGEF3 mRNA | 3p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF4 | 50649 |
downregulated | Tretinoin results in decreased expression of ARHGEF4 mRNA | 2q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF40 | 55701 |
upregulated | Tretinoin results in increased expression of ARHGEF40 mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF7 | 8874 |
upregulated | Tretinoin results in increased expression of ARHGEF7 mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | ARHGEF9 | 23229 |
downregulated | Tretinoin results in decreased expression of ARHGEF9 mRNA | Xq11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARID5B | 84159 |
upregulated | Tretinoin results in increased expression of ARID5B mRNA | 10q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARL4C | 10123 |
downregulated | Tretinoin results in decreased expression of ARL4C mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARL6IP5 | 10550 |
upregulated | Tretinoin results in increased expression of ARL6IP5 mRNA | 3p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARMC4 | 55130 |
downregulated | Tretinoin results in decreased expression of ARMC4 mRNA | 10p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARMC9 | 80210 |
upregulated | Tretinoin results in increased expression of ARMC9 mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARMCX3 | 51566 |
upregulated | Tretinoin results in increased expression of ARMCX3 mRNA | Xq22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARNTL | 406 |
downregulated | Tretinoin results in decreased expression of ARNTL mRNA | 11p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARPC1B | 10095 |
upregulated | Tretinoin results in increased expression of ARPC1B mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ARPC3 | 10094 |
upregulated | Tretinoin results in increased expression of ARPC3 mRNA | 12q24.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ARPP19 | 10776 |
downregulated | Tretinoin results in decreased expression of ARPP19 mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARPP19 | 10776 |
upregulated | Tretinoin results in increased expression of ARPP19 mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARPP21 | 10777 |
upregulated | Tretinoin results in increased expression of ARPP21 mRNA | 3p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARRB2 | 409 |
downregulated | Tretinoin results in decreased expression of ARRB2 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ARRDC2 | 27106 |
downregulated | Tretinoin results in decreased expression of ARRDC2 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ARRDC3 | 57561 |
upregulated | Tretinoin results in increased expression of ARRDC3 mRNA | 5q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ARSJ | 79642 |
downregulated | Tretinoin results in decreased expression of ARSJ mRNA | 4q26 | |
| Tretinoin | Approved Investigational Nutraceutical | ASAH1 | 427 |
upregulated | Tretinoin results in increased expression of ASAH1 mRNA | 8p22 | |
| Tretinoin | Approved Investigational Nutraceutical | ASB3 | 51130 |
upregulated | Tretinoin results in increased expression of ASB3 mRNA | 2p16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ASB9 | 140462 |
downregulated | Tretinoin results in decreased expression of ASB9 mRNA | Xp22.2 | |